《STN125011TositumomabTherapeuticRegimen(TTR)[tosit》.pptVIP

STN 125011 Tositumomab Therapeutic Regimen (TTR)[tositumomab plus I-131 tositumomab] Oncologic Drugs Advisory Committee December 17, 2002 Proposed Indication Treatment of Patients with Relapsed or Refractory, Low-Grade, Follicular, or Transformed Low-Grade Non-Hodgkin’s Lymphoma (NHL) including Patients with Rituximab-Refractory Follicular NHL OVERVIEW OF CLINICAL STUDIESEfficacy Study RIT-II-004 - The primary efficacy trial supporting the request for accelerated approval for the treatment of chemotherapy-refractory patients with low grade and follicular NHL, with or without transformati